Add Formweb to your mobile device
System Formulary Update
Isradipine
Situation
Isradipine formulary addition request was approved at the April 2021 System Pharmacy and Therapeutics Committee meeting.
Background
The following medications were reviewed: isradipine
Assessment/Recommendation
Changes effective: Tuesday, June 29, 2021
System P&T voted to include the following products on the UNC Health Medication Formulary:
- Isradipine 2.5 mg capsule – restricted to pediatric use only
- Isradipine 1 mg/mL oral suspension (extemporaneously compounded) – restricted to pediatric use only
Note: Stock of these formulary products may vary at individual entities
Non-formulary orders will be converted according to the following therapeutic interchange:
|
Calcium Channel Blockers, Dihydropyridine |
||
|
Non-Formulary Order |
Formulary Equivalent Order |
|
|
Isradipine capsule, IR 2.5 mg twice daily 5 mg twice daily 10 mg twice daily |
Adult Formulary Equivalent Order |
Pediatric Equivalent Order |
|
Amlodipine tablet 5 mg daily 10 mg daily 10 mg daily |
Not applicable |
|